INTERMED.CAP.GRP.LS-,2625 financial statements, including revenue, expenses, profit, and loss
The total revenue of I2X2 for the last semiannual is 553.26 M EUR, and it's 18.93% higher compared to the previous semiannual. The net income of H1 23 is 259.61 M EUR.